This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

The MarketWatch News Department was not involved in the creation of this content.-- Kytopen continues expanding its partnership footprint in Europe through a new agreement with TQ ...

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen Dong of the Institute of ...

SEATTLE, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pluristyx, Inc. today announced the formation of the Organoid COMMONS (Consortium for Organoid Manufacturing, Measurement, Optimization, and Network ...

Rigel Pharmaceuticals, Inc. posted a solid Q3 with robust sales growth. Discover insights on future profitability and market ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

The performance of skilled behaviors requires a balance between consistency and adaptability. Although the neural mechanisms that regulate this balance have been extensively studied at systems and ...